Monday, June 2, 2014
fei: Anti-Doping & Controlled Medication
The use of substances with the potential to affect equine performance, health or welfare and/or with a high potential for misuse are contrary to the integrity of equestrian sport and the welfare of the horses.
The FEI provides a list of substances prohibited for use in horses competing at FEI events – the FEI Equine Prohibited Substances List. This list consists of two groups of substances: banned and controlled medication. Banned substances are not permitted for use in horses competing. Controlled medications are acknowledged as substances with therapeutic veterinary benefits but are not permitted during FEI events because of the potential for their misuse.
Testing programmes and protocols are implemented to detect the presence of prohibited substances in horses competing. Urine and/or blood samples from horses tested are sent by courier to one of five FEI Laboratories.
Negative blood and urine analysis results within the programme are updated regularly on the website for Groups I and II only and can be accessed here.
Before giving any substance to a horse competing at FEI events, athletes and their support personnel should always check, if it is prohibited under the FEI Rules by using the FEI Prohibited Substances database. They should work with veterinary advisers to establish a safe withdrawal time before competing. Horses must never compete unless they are fit to do so. During events, the administration of treatments and supportive therapies must be authorised by the veterinary delegate or commission before administration, using the appropriate veterinary form. The veterinary forms are available by clicking here.
Permitted Substances of interest to equine feed industry
The FEI Rules and Regulations permit the use of certain substances such as:
- B-vitamins, amino acids and electrolytes. These have always been allowed orally and in many cases this is still the preferred route of administration. However in some circumstances a veterinarian may prefer to administer them intravenously or intramuscularly.
- Preventative or restorative joint therapies. Many of these products in the oral form (chondroitin, glucosamine, etc.) have always been allowed orally and in many cases this is the preferred route of administration. However in some circumstances a veterinarian may prefer to administer joint restorative therapy intravenously or intramuscularly.
The FEI cautions however athletes, trainers, grooms and veterinarians against the use of herbal medications, tonics, oral pastes and products of which the detailed ingredients and quantitative analysis are unknown and could therefore contain one or more Prohibited Substances. Moreover, the persons administering a herbal or so-called natural product to a horse or pony for health reasons or to affect its performance, who have been informed that the plant of origin or its ingredients do not violate the FEI regulations, may have been misinformed. The use of any herbal or natural product to affect the performance of a horse or pony in a calming (tranquillizing) or an energizing (stimulant) manner is expressly forbidden by the FEI regulations. The use of a calming product during competition may also have important safety consequences.
For the latest Equine Anti-Doping and Controlled Medication Regulations in place, please click here.
For medication control at FEI events, please refer to the Veterinary Regulations. We have added for your convenience the following educational documents: Athletes' Guide to Anti-Doping (pdf) and How Testing Works (pdf).Information on FEI Laboratories:
Other useful links:
- Prohibited Substances List
- List of Detection Times (pdf)
- FAQs on FEI process for EADCM procedures (pdf)
- QUOTED FROM HERE
FDA Warns More Compounders Under New Authority in DQSA
Jun. 02, 2014
The FDA has warned two more compounding pharmacies for actions that occurred prior to passage of a new federal law that boosted the agency’s authority over such facilities.
Read More
Read More
HORSE DOPING- A Compounded Tragedy by Rick Dennis June 2, 2014
Recently HBO aired a segment of Real Sports with Bryant Gumbel featuring a documentary on Horse Doping and its effects on Thoroughbred horses on the racetrack.
Besides exposing yet another ominous side of the horse industry, the documentary illustrated the abuse horses are receiving in the “The Sport of Kings” for the amusement and satisfaction of horse owners, track owners, trainers and spectators alike from modern drug preparations.
The outright disgusting side of the sport is clearly illustrated by a horse being put down on the far side of a racetrack. A simple hole was dug in the ground that contained the carcasses of euthanized horses. Not a very pleasant site for the general audience, especially animal lovers! Notwithstanding, the main theme of the documentary is horse doping and its adverse effects drugs have on the on the racehorse.
continue to read here
Louisiana shelves execution secrecy law
A bill in Louisiana that would have given the state one of the toughest execution secrecy regimes in the US has been pulled by its Republican sponsor at the last minute.
Observers had expected the bill, HB 328, to go through without difficulty. It had already received the approval of both houses of the state legislature and was awaiting final agreement on amendments. Among its provisions HB 328 would have prevented the public from knowing the source of the state's lethal injection drugs.
But with just hours to go before the end of the assembly's legislative session its proposer, Joe Lopinto, killed the bill unilaterally. He told reporters from local papers that he had decided in the wake of the recent uproar over botched executions in other states to play a longer game.
“We passed a resolution today to study this issue. There’s no reason for us to rush through and pass piecemeal legislation that will only be a short-term fix for something that needs a long-term solution,” Lopinto told the Shreveport Times.
continue to read here
Observers had expected the bill, HB 328, to go through without difficulty. It had already received the approval of both houses of the state legislature and was awaiting final agreement on amendments. Among its provisions HB 328 would have prevented the public from knowing the source of the state's lethal injection drugs.
But with just hours to go before the end of the assembly's legislative session its proposer, Joe Lopinto, killed the bill unilaterally. He told reporters from local papers that he had decided in the wake of the recent uproar over botched executions in other states to play a longer game.
“We passed a resolution today to study this issue. There’s no reason for us to rush through and pass piecemeal legislation that will only be a short-term fix for something that needs a long-term solution,” Lopinto told the Shreveport Times.
continue to read here
CVS Hiring Compounding Pharmacist
Job: Pharmacist - Infusion Compounding
Click Here toApply Online
Recruiting In, Tampa, FL 33634
Share
Posted: 06/02/2014
Job Status: Full Time
Job Reference #: 169758BR
Jobing Description
Pharmacist - Infusion CompoundingReq ID 169758BR
Business Area Coram CVS/specialty infusion services
Job Category Pharmacist
Position Summary
Join the Coram CVS/specialty infusion services team as a Pharmacist working on the infusion compounding team. As part of an industry leader you'll support a business that provides cost-effective solutions and high-quality patient care for those receiving specialized and complex therapies administered in their homes.
Key responsibilities
* Obtain, interpret and evaluate all physician medication orders for therapeutic appropriateness, cost effectiveness, accuracy, safety and completeness.
* Participate in patient evaluation for acceptance, product selection, device selection and supply management.
* Directly supervise pharmacy support personnel in the appropriate compounding, packaging and labeling of compounded sterile products.
* Check compounded sterile products, computer order-entry and manage the pharmacy clean room suite to 797 requirements.
* Communicate clinical and technical information with other members of healthcare team.
* Assist in training and orientation of new employees, performance improvement activities and educational programs. Participate in on call rotation as indicated by staffing and business needs.
Required Qualifications
* Registered Pharmacist with current license in state of employment. Additional licensure may be required in multi state service areas.
* Minimum 1 year infusion therapy compounding experience.
* Must have and maintain current CPR certification if in direct contact with patients.
* Excellent customer service skills (written and verbal) a must.
Preferred Qualifications
* Home healthcare infusion therapy compounding experience preferred.
Education
B.S. or doctorate of pharmacy degree
Clinical Licensure Required Pharmacist
Job Type Full Time
Business Overview
Coram CVS/specialty infusion services is a leading national provider of specialty home infusion and specialty pharmacy services. The integration of Coram into CVS Caremark enables the company to offer enhanced, comprehensive infusion services; expanded payer access; and a national network of more than 85 locations, including 65 ambulatory infusion suites. Providing infusion therapies and services to over 20,000 patients each month, Coram cares for patients through all phases of their healthcare continuum, with services including clinical and compliance monitoring, and individual patient counseling and education.CVS Caremark, through our unmatched breadth of service offerings, is transforming the delivery of health care services in the U.S. Our energetic and service-oriented colleagues make a positive difference in the lives of our patients. As the nation's largest pharmacy health care provider, we offer exciting career opportunities embracing fresh ideas, new perspectives, a diversity of experiences, and a dedication to service to meet the needs of the many people and businesses relying on us each day.CVS Caremark is an equal opportunity employer. We do not discriminate in hiring or employment against any individual on the basis of race, color, gender, national origin, ancestry, religion, physical or mental disability, age, veteran status, sexual orientation, gender identity or expression, marital status, pregnancy, citizenship, or any other factor protected by anti-discrimination laws. Furthermore, we comply with the laws and regulations set forth in the following EEO is the Law Poster: EEO IS THE LAWFederal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. If you require assistance to apply for this job, please contact us by clicking
AA EEO CVS Caremark
Skills / Requirements
Pfizer to pay $325M fine to third party payers • 8:39 PM
- Without admitting wrongdoing, Pfizer (PFE +0.3%) agrees to pay $325M to certain third party payers to settle allegations that it defrauded insurers and other healthcare benefit providers by marketing Neurotonin for unapproved uses.
- On April 21, the company agreed to pay $190M to settle litigation in New Jersey. The case was brought by Neurotonin buyers who accused it of taking steps to keep cheaper generic versions of the drug off the market.
- In May 2004 PFE agreed to pay $430M and plead guilty to criminal charges for illegally marketing Neurotonin for unapproved uses.
- The company acquired Neurotonin when in bought Warner-Lambert in 2000.
Subscribe to:
Posts (Atom)